Lenvatinib: beside a new treatment under test
104 studies: a new drug, cell therapy or vaccine is what the study tests. Page 2 of 2. Open to participants first (60), then studies with results posted, then the rest; newest registration first within each.
- A Study of E7386 in Combination With Other Anticancer Drug(s) in Participants With Solid TumorActive, not recruitingNCT04008797Phase 1/2Report a problem
- Toripalimab in Combination With Lenvatinib as Neoadjuvant Therapy in Resectable Hepatocellular CarcinomaTerminatedNCT03867370Phase 1/2Report a problem
- A Study to Evaluate MIV-818 in Patients With Liver Cancer ManifestationsCompletedNCT03781934Phase 1/2Report a problem
- Study of MK-4830 as Monotherapy and in Combination With Pembrolizumab (MK-3475) in Participants With Advanced Solid Tumors (MK-4830-001)CompletedNCT03564691Phase 1Report a problem